{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T01:39:32Z","timestamp":1769737172109,"version":"3.49.0"},"reference-count":30,"publisher":"Bentham Science Publishers Ltd.","issue":"11","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDD"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Breviscapine (BVP) is one of the extracts of several flavonoids of Erigeron\nbreviscapus, which has been widely used in the treatment of cerebral infarction and its sequelae,\ncerebral thrombus, coronary heart disease, and angina pectoris. But BVP has poor solubility.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>The objective of the study is to develop mesoporous silica nanoparticles (MSNs) that can\nbe loaded with a drug with poor water solubility. The MSNs, which were designed for oral administration,\nenhanced both the dissolution rate and drug loading capacity.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>The use of MSNs as an oral drug delivery system was investigated by SEM, TEM, BETBJH,\nXRD, FT-IR, and HPLC. Additionally, we examined the oral bioavailability of BVP loaded\nonto MSNs and examined the cellular cytotoxicity of MSNs.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The results indicate that the oral bioavailability of BVP after loading onto MSNs was greater\nthan that of a marketed product. Furthermore, we studied the mechanism by which MSNs enhance\nthe oral absorption of BVP.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>MSNs have the potential to enhance the oral bioavailability of poorly water-soluble\ndrugs by accelerating the drug dissolution rate.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0115672018273792240101062603","type":"journal-article","created":{"date-parts":[[2024,2,4]],"date-time":"2024-02-04T11:58:32Z","timestamp":1707047912000},"page":"1529-1536","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Preparation, Characterization, and Evaluation of Mesoporous Silica Nanoparticles in Enhancing Oral Bioavailability of Poorly Water-Soluble Drugs"],"prefix":"10.2174","volume":"21","author":[{"given":"Hong","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Tianjin Chest Hospital, Tianjin, 300222, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanjiao","family":"Zuo","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Medicine,\nTianjin University of Traditional Chinese Medicine, Tianjin, 301617, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boyao","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Medicine,\nTianjin University of Traditional Chinese Medicine, Tianjin, 301617, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xilong","family":"Qiu","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Medicine,\nTianjin University of Traditional Chinese Medicine, Tianjin, 301617, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.addr.2007.05.003","volume":"59","author":"Kesisoglou F.","year":"2007","unstructured":"Kesisoglou F.; Panmai S.; Wu Y.; Nanosizing - Oral formulation development and biopharmaceutical evaluation. Adv Drug Deliv Rev  2007,59(7),631-644","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1021\/mp0600182","volume":"3","author":"Takagi T.","year":"2006","unstructured":"Takagi T.; Ramachandran C.; Bermejo M.; Yamashita S.; Yu L.X.; Amidon G.L.; A provisional biopharmaceutical classification of the top 200 oral drug products in the United States, Great Britain, Spain, and Japan. Mol Pharm  2006,3(6),631-643","journal-title":"Mol Pharm"},{"key":"ref=3","first-page":"82","volume":"5","author":"Lipinski C.","year":"2002","unstructured":"Lipinski C.; Poor aqueous solubility-an industry wide problem in drug discovery. Am Pharm Rev  2002,5,82-85","journal-title":"Am Pharm Rev"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jcis.2014.08.019","volume":"434","author":"Jambhrunkar S.","year":"2014","unstructured":"Jambhrunkar S.; Qu Z.; Popat A.; Karmakar S.; Xu C.; Yu C.; Modulating in vitro release and solubility of griseofulvin using functionalized mesoporous silica nanoparticles. J Colloid Interface Sci  2014,434,218-225","journal-title":"J Colloid Interface Sci"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.drudis.2007.09.005","volume":"12","author":"Vasconcelos T.","year":"2007","unstructured":"Vasconcelos T.; Sarmento B.; Costa P.; Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov Today  2007,12(23-24),1068-1075","journal-title":"Drug Discov Today"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1002\/adma.200400771","volume":"16","author":"Barb\u00e9 C.","year":"2004","unstructured":"Barb\u00e9 C.; Bartlett J.; Kong L.; Finnie K.; Lin H.Q.; Larkin M.; Calleja S.; Bush A.; Calleja G.; Silica particles: A novel drug-delivery system. Adv Mater  2004,16(21),1959-1966","journal-title":"Adv Mater"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1021\/cm0011559","volume":"13","author":"Vallet-Regi M.","year":"2001","unstructured":"Vallet-Regi M.; R\u00e1mila A.; del Real R.P.; P\u00e9rez-Pariente J.; A new property of MCM-41: Drug delivery system. Chem Mater  2001,13(2),308-311","journal-title":"Chem Mater"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1039\/c0nr00156b","volume":"2","author":"Rosenholm J.M.","year":"2010","unstructured":"Rosenholm J.M.; Sahlgren C.; Lind\u00e9n M.; Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles \u2013 opportunities and challenges. Nanoscale  2010,2(10),1870-1883","journal-title":"Nanoscale"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1002\/smll.200900923","volume":"5","author":"He Q.","year":"2009","unstructured":"He Q.; Zhang Z.; Gao Y.; Shi J.; Li Y.; Intracellular localization and cytotoxicity of spherical mesoporous silica nano- and microparticles. Small  2009,5(23),2722-2729","journal-title":"Small"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1039\/c1cs15246g","volume":"41","author":"Li Z.","year":"2012","unstructured":"Li Z.; Barnes J.C.; Bosoy A.; Stoddart J.F.; Zink J.I.; Mesoporous silica nanoparticles in biomedical applications. Chem Soc Rev  2012,41(7),2590-2605","journal-title":"Chem Soc Rev"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"6906","DOI":"10.1021\/ja102414t","volume":"132","author":"Lei C.","year":"2010","unstructured":"Lei C.; Liu P.; Chen B.; Mao Y.; Engelmann H.; Shin Y.; Jaffar J.; Hellstrom I.; Liu J.; Hellstrom K.E.; Local release of highly loaded antibodies from functionalized nanoporous support for cancer immunotherapy. J Am Chem Soc  2010,132(20),6906-6907","journal-title":"J Am Chem Soc"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1002\/chem.201304864","volume":"20","author":"Zhou Y.","year":"2014","unstructured":"Zhou Y.; Tan L.L.; Li Q.L.; Qiu X.L.; Qi A.D.; Tao Y.; Yang Y.W.; Acetylcholine-triggered cargo release from supramolecular nanovalves based on different macrocyclic receptors. Chemistry  2014,20(11),2998-3004","journal-title":"Chemistry"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.2147\/IJN.S238337","volume":"15","author":"Yang G.","year":"2020","unstructured":"Yang G.; Li Z.; Wu F.; Chen M.; Wang R.; Zhu H.; Li Q.; Yuan Y.; Improving solubility and bioavailability of breviscapine with mesoporous silica nanoparticles prepared using ultrasound-assisted solution-enhanced dispersion by supercritical fluids method. Int J Nanomedicine  2020,15,1661-1675","journal-title":"Int J Nanomedicine"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.msec.2014.10.067","volume":"47","author":"Hu L.","year":"2015","unstructured":"Hu L.; Sun H.R.; Zhao Q.F.; Multilayer encapsulated mesoporous silica nanospheres as an oral sustained drug delivery system for the poorly water-soluble drug felodipine. Mater Sci Eng C Mater Biol Appl  2015,47,313-324","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"120301","DOI":"10.1016\/j.lfs.2022.120301","volume":"291","author":"Khan K.U.","year":"2022","unstructured":"Khan K.U.; Minhas M.U.; Badshah S.F.; Suhail M.; Ahmad A.; Ijaz S.; Overview of nanoparticulate strategies for solubility enhancement of poorly soluble drugs. Life Sci  2022,291,120301","journal-title":"Life Sci"},{"key":"ref=16","first-page":"371","volume":"38","author":"Jiang X.H.","year":"2003","unstructured":"Jiang X.H.; Li S.H.; Lan K.; Yang J.Y.; Zhou J.; [Study on the pharmacokinetics of scutellarin in dogs]. Yao Xue Xue Bao  2003,38(5),371-373","journal-title":"Yao Xue Xue Bao"},{"key":"ref=17","first-page":"775","volume":"38","author":"Liu Y.M.","year":"2003","unstructured":"Liu Y.M.; Lin A.H.; Chen H.; Zeng F.D.; Study on pharmacokinetics of scutellarin in rabbits. Yao Xue Xue Bao  2003,38(10),775-778","journal-title":"Yao Xue Xue Bao"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.ijrobp.2006.09.011","volume":"67","author":"Goh A.S.W.","year":"2007","unstructured":"Goh A.S.W.; Chung A.Y.F.; Lo R.H.G.; Lau T.N.; Yu S.W.K.; Chng M.; Satchithanantham S.; Loong S.L.E.; Ng D.C.E.; Lim B.C.; Connor S.; Chow P.K.H.; A novel approach to brachytherapy in hepatocellular carcinoma using a phosphorous32 (32P) brachytherapy delivery device-a first-in-man study. Int J Radiat Oncol Biol Phys  2007,67(3),786-792","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"11636","DOI":"10.1021\/ja0511671","volume":"127","author":"Pacholski C.","year":"2005","unstructured":"Pacholski C.; Sartor M.; Sailor M.J.; Cunin F.; Miskelly G.M.; Biosensing using porous silicon double-layer interferometers: Reflective interferometric Fourier transform spectroscopy. J Am Chem Soc  2005,127(33),11636-11645","journal-title":"J Am Chem Soc"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"6355","DOI":"10.1039\/D1BM00639H","volume":"9","author":"Guo L.","year":"2021","unstructured":"Guo L.; Zhang Y.; Al-Jamal K.T.; Recent progress in nanotechnology-based drug carriers for celastrol delivery. Biomater Sci  2021,9(19),6355-6380","journal-title":"Biomater Sci"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/pssa.200723113","volume":"205","author":"Prestidge C.A.","year":"2008","unstructured":"Prestidge C.A.; Barnes T.J.; Mierczynska-Vasilev A.; Kempson I.; Peddie F.; Barnett C.; Peptide and protein loading into porous silicon wafers. Phys Status Solidi, A Appl Mater Sci  2008,205(2),311-315","journal-title":"Phys Status Solidi, A Appl Mater Sci"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jconrel.2005.08.017","volume":"108","author":"Salonen J.","year":"2005","unstructured":"Salonen J.; Laitinen L.; Kaukonen A.M.; Tuura J.; Bj\u00f6rkqvist M.; Heikkil\u00e4 T.; V\u00e4h\u00e4-Heikkil\u00e4 K.; Hirvonen J.; Lehto V.P.; Mesoporous silicon microparticles for oral drug delivery: Loading and release of five model drugs. J Control Release  2005,108(2-3),362-374","journal-title":"J Control Release"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1016\/j.addr.2008.03.017","volume":"60","author":"Anglin E.","year":"2008","unstructured":"Anglin E.; Cheng L.; Freeman W.; Sailor M.; Porous silicon in drug delivery devices and materials. Adv Drug Deliv Rev  2008,60(11),1266-1277","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"9033","DOI":"10.1039\/c3cc45216f","volume":"49","author":"Sun Y.L.","year":"2013","unstructured":"Sun Y.L.; Zhou Y.; Li Q.L.; Yang Y.W.; Enzyme-responsive supramolecular nanovalves crafted by mesoporous silica nanoparticles and choline-sulfonatocalix[4]arene [2]pseudorotaxanes for controlled cargo release. Chem Commun  2013,49(79),9033-9035","journal-title":"Chem Commun"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejps.2011.10.016","volume":"45","author":"Vadia N.","year":"2012","unstructured":"Vadia N.; Rajput S.; Study on formulation variables of methotrexate loaded mesoporous MCM-41 nanoparticles for dissolution enhancement. Eur J Pharm Sci  2012,45(1-2),8-18","journal-title":"Eur J Pharm Sci"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1021\/nl404316v","volume":"14","author":"Shen D.","year":"2014","unstructured":"Shen D.; Yang J.; Li X.; Zhou L.; Zhang R.; Li W.; Chen L.; Wang R.; Zhang F.; Zhao D.; Biphase stratification approach to three-dimensional dendritic biodegradable mesoporous silica nanospheres. Nano Lett  2014,14(2),923-932","journal-title":"Nano Lett"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1080\/10717544.2022.2086940","volume":"29","author":"Peng T.","year":"2022","unstructured":"Peng T.; Xu T.; Liu X.; Research progress of the engagement of inorganic nanomaterials in cancer immunotherapy. Drug Deliv  2022,29(1),1914-1932","journal-title":"Drug Deliv"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1080\/10837450.2017.1295065","volume":"23","author":"Ibrahim A.H.","year":"2018","unstructured":"Ibrahim A.H.; Ibrahim H.M.; Ismael H.R.; Samy A.M.; Optimization and evaluation of lyophilized fenofibrate nanoparticles with enhanced oral bioavailability and efficacy. Pharm Dev Technol  2018,23(4),358-369","journal-title":"Pharm Dev Technol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.jconrel.2017.07.047","volume":"262","author":"Maleki A.","year":"2017","unstructured":"Maleki A.; Kettiger H.; Schoubben A.; Rosenholm J.M.; Ambrogi V.; Hamidi M.; Mesoporous silica materials: From physico-chemical properties to enhanced dissolution of poorly water-soluble drugs. J Control Release  2017,262,329-347","journal-title":"J Control Release"},{"key":"ref=30","first-page":"992","volume":"100","author":"Moritz M","year":"2021","unstructured":"Moritz M; Geszke-Moritz M;  Mesoporous materials as adsorbents for biologically active substances  2021,100(10),992-994","journal-title":"Mesoporous materials as adsorbents for biologically active substances"}],"container-title":["Current Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115672018273792240101062603","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/225705\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115672018273792240101062603","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T10:58:57Z","timestamp":1730890737000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/225705\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115672018273792240101062603","relation":{},"ISSN":["1567-2018"],"issn-type":[{"value":"1567-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-09-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-18","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}